213 related articles for article (PubMed ID: 33393939)
1. Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
.
Förster-Ruhrmann U; Tietz AK; Kim J; Liebers U; Szczepek AJ; Olze H
Allergol Select; 2020; 4():135-143. PubMed ID: 33393939
[TBL] [Abstract][Full Text] [Related]
2. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
Förster-Ruhrmann U; Behrbohm W; Pierchalla G; Szczepek AJ; Fluhr JW; Olze H
HNO; 2019 Aug; 67(8):620-627. PubMed ID: 31069402
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab in patients with NSAIDs-exacerbated respiratory disease.
Forster-Ruhrmann U; Stergioudi D; Pierchalla G; Fluhr JW; Bergmann KC; Olze H
Rhinology; 2020 Jun; 58(3):226-232. PubMed ID: 32077449
[TBL] [Abstract][Full Text] [Related]
4. Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
Foerster-Ruhrmann U; Jurkov M; Szczepek AJ; Bergmann KC; Fluhr JW; Olze H
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790987
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
[TBL] [Abstract][Full Text] [Related]
6. [Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease].
Förster-Ruhrmann U; Olze H
HNO; 2024 Jul; 72(7):494-498. PubMed ID: 38597968
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
8. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
Busse WW; Pavord ID; Siddiqui S; Khan AH; Praestgaard A; Nash S; Jacob-Nara JA; Rowe PJ; Deniz Y
J Asthma Allergy; 2023; 16():411-419. PubMed ID: 37096015
[TBL] [Abstract][Full Text] [Related]
10. High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients.
Laulajainen-Hongisto A; Turpeinen H; Vento SI; Numminen J; Sahlman J; Kauppi P; Virkkula P; Hytönen M; Toppila-Salmi S
J Allergy Clin Immunol Pract; 2020; 8(10):3565-3574. PubMed ID: 32693216
[TBL] [Abstract][Full Text] [Related]
11. The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids.
Bartosik TJ; Campion NJ; Freisl K; Liu DT; Gangl K; Stanek V; Tu A; Pjevac P; Hausmann B; Eckl-Dorna J; Schneider S
Front Immunol; 2023; 14():1112345. PubMed ID: 37122714
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
[TBL] [Abstract][Full Text] [Related]
13. Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD.
Tepetam FM; Özden Ş; Kılıç FK; Örçen C; Yakut T
World Allergy Organ J; 2023 Sep; 16(9):100817. PubMed ID: 37771938
[TBL] [Abstract][Full Text] [Related]
14. Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID â€" intolerance.
Steiner UC; Bischoff S; Valaperti A; Ikenberg K; Starzyk J; Bucher S; Bachmann LM; Soyka MB
Rhinology; 2020 Dec; 58(6):544-549. PubMed ID: 32692786
[TBL] [Abstract][Full Text] [Related]
15. Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.
Ramírez-Jiménez F; Vázquez-Corona A; Sánchez-de la Vega Reynoso P; Pavón-Romero GF; Jiménez-Chobillon MA; Castorena-Maldonado AR; Teran LM
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1554-1561. PubMed ID: 33160093
[TBL] [Abstract][Full Text] [Related]
16. Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps.
De Corso E; Baroni S; Settimi S; Onori ME; di Cesare T; Mastrapasqua RF; Sarlo F; Penazzi D; D'Agostino G; D'Auria LM; De Maio G; Fetoni AR; Galli J
Int Forum Allergy Rhinol; 2024 Jan; ():. PubMed ID: 38266634
[TBL] [Abstract][Full Text] [Related]
17. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors.
Nabavi M; Esmaeilzadeh H; Arshi S; Bemanian MH; Fallahpour M; Bahrami A; Mortazavi N; Kamrava K; Farhadi M; Taghipour R; Rezaei N
Am J Rhinol Allergy; 2014; 28(3):239-43. PubMed ID: 24980235
[TBL] [Abstract][Full Text] [Related]
18. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Bachert C; Laidlaw TM; Cho SH; Mullol J; Swanson BN; Naimi S; Classe M; Harel S; Jagerschmidt A; Laws E; Ruddy M; Praestgaard A; Amin N; Mannent LP
Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1649-1661. PubMed ID: 37322842
[TBL] [Abstract][Full Text] [Related]
19. Eicosanoid imbalance correlates in vitro with the pattern of clinical symptoms of Samter's triad.
Forster U; Strathmann S; Schafer D; Szczepek AJ; Olze H
Rhinology; 2013 Mar; 51(1):61-9. PubMed ID: 23441313
[TBL] [Abstract][Full Text] [Related]
20. Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
Vaidyanathan S; Williamson PA; Lipworth BJ
Am J Rhinol Allergy; 2012; 26(3):e89-93. PubMed ID: 22643934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
